Team:Grenoble-EMSE-LSU/Documentation/Notebook/May
From 2013.igem.org
(7 intermediate revisions not shown) | |||
Line 17: | Line 17: | ||
<ul class="texte"> | <ul class="texte"> | ||
<li id="titre"> | <li id="titre"> | ||
+ | |||
+ | |||
<h1>May</h1> | <h1>May</h1> | ||
+ | |||
<h2>Week 4 (20-24)</h2> | <h2>Week 4 (20-24)</h2> | ||
<h3>Monday</h3><br><br> | <h3>Monday</h3><br><br> | ||
Line 26: | Line 29: | ||
<p>We spend some time discovering the equipment at our disposal, how it works and what it can and can't do. We have access to a microplate reader (absorbance and fluorescence), a spectrophotometer (absorbance), an inverted fluorescence microscope, a PCR machine an, multiple centrifuges and electrophoresis machines, and plenty of pipetmans, plastic disposables and gloves. I'm sure there's a couple of things I've forgotten on the list, but at least we know we have what's necessary to start on great footing.<br><br> | <p>We spend some time discovering the equipment at our disposal, how it works and what it can and can't do. We have access to a microplate reader (absorbance and fluorescence), a spectrophotometer (absorbance), an inverted fluorescence microscope, a PCR machine an, multiple centrifuges and electrophoresis machines, and plenty of pipetmans, plastic disposables and gloves. I'm sure there's a couple of things I've forgotten on the list, but at least we know we have what's necessary to start on great footing.<br><br> | ||
- | We have transformed fresh cells with a GFP gene controlled by a PBad promoter using < | + | We have transformed fresh cells with a GFP gene controlled by a PBad promoter using <a href="https://static.igem.org/mediawiki/2013/f/fe/Grenoble_Protocols-TSS_Transformations.pdf"> the TSS method</a></p> |
<h3>Wednesday</h3><br><br> | <h3>Wednesday</h3><br><br> | ||
Line 45: | Line 48: | ||
<p>Meeting with Yohan Roulland at the Institut Albert Bonniot (Grenoble medical campus), regarding the use of KillerRed.</br> | <p>Meeting with Yohan Roulland at the Institut Albert Bonniot (Grenoble medical campus), regarding the use of KillerRed.</br> | ||
Information obtained: KillerRed is more effective as a dimer, whereas the gene itself only codes for a monomer. The dimer form can be obtained by fusing one KillerRed protein to another directly after it on the gene, or by fusing it with two different proteins which operate close to each other in the cell, thereby bringing their respective KillerRed proteins close enough for dimerization to occur.</br> | Information obtained: KillerRed is more effective as a dimer, whereas the gene itself only codes for a monomer. The dimer form can be obtained by fusing one KillerRed protein to another directly after it on the gene, or by fusing it with two different proteins which operate close to each other in the cell, thereby bringing their respective KillerRed proteins close enough for dimerization to occur.</br> | ||
- | Expression of KillerRed in the cytoplasm of different organelles in eukaryotic cells hasn’t had any effect: expression in the cytoplasm of the nucleus didn’t successfully kill the cells. Since it is most probable that bacteria are more resistant to oxidative damage than eukaryotes, this would mean that a specific target protein needs to be chosen in E. | + | Expression of KillerRed in the cytoplasm of different organelles in eukaryotic cells hasn’t had any effect: expression in the cytoplasm of the nucleus didn’t successfully kill the cells. Since it is most probable that bacteria are more resistant to oxidative damage than eukaryotes, this would mean that a specific target protein needs to be chosen in <em>E. coli</em> so as to significantly damage the cell and kill it when KillerRed produced ROS.</br></br> |
Experiments</br> | Experiments</br> | ||
As the first experiment didn’t yield any quantitative information, we need to develop a rigorous protocol in order to substract background noise from fluorescence measurements more precisely, as well as prove that only the bacteria that have been transformed with the correct plasmid, and induced with arabinose, are actually fluorescing.</br> | As the first experiment didn’t yield any quantitative information, we need to develop a rigorous protocol in order to substract background noise from fluorescence measurements more precisely, as well as prove that only the bacteria that have been transformed with the correct plasmid, and induced with arabinose, are actually fluorescing.</br> | ||
Line 58: | Line 61: | ||
<h2>Week 5 (27-31)</h2> | <h2>Week 5 (27-31)</h2> | ||
<h3>Monday</h3> | <h3>Monday</h3> | ||
+ | <br><br><p> | ||
+ | PBAD promoter characterization: we decided to try and characterize the behaviour of PBAD according to the concentration of arabinose in the media. It is more rigorous than the first PBAD experiment we did.<br><br> | ||
+ | We used E. coli BW25113 transformed with PBAD-GFP (Kanamycin resistance in the plasmid), and untransformed BW25113 as control. Cultures were saturated over the weekedn before the experiment.<br><br> | ||
+ | We used decreasing concentrations of arabinose ranging from 0.1% to 0.00016% with 5X dilutions.<br><br> | ||
+ | Results show fluorescence starts rising after 3 hours of incubation on microplates. | ||
+ | </p><br><br> | ||
<h3>Tuesday</h3> | <h3>Tuesday</h3> | ||
+ | |||
<h3>Wednesday</h3> | <h3>Wednesday</h3> | ||
+ | <br><br><p>In order to obtain better results in terms of fluorescence and in terms of bacterial growth control, we choose to use <a href="https://static.igem.org/mediawiki/2013/5/50/Grenoble_Preparation_of_M9_medium.pdf">M9</a> for a second experiment to characterize PBAD.<br><br> | ||
+ | M9 is supplemented in glucose. We use <em>E. coli</em> BW25113 which is a prototroph.<br><br> | ||
+ | The protocol used is available on the internet. The experiment failed for multiple reasons including lack of controls, lack of time to do every step every 30 minutes. | ||
<h3>Thursday</h3> | <h3>Thursday</h3> | ||
<h3>Friday</h3> | <h3>Friday</h3> |
Latest revision as of 01:00, 5 October 2013